Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence
Ontology highlight
ABSTRACT: We performed longitudinal blood sampling of end-stage kidney disease (ESKD) patients with COVID-19, collecting samples pre-infection and serially during infection. SomaLogic proteomics data were generated for two cohorts. The Wave 1 cohort consists of samples collected from ESKD patients during the first wave of COVID-19 in early 2020, while samples were collected for the Wave 2 cohort in the following year. A full analysis of the dataset is presented in the Nature Communications manuscript (https://doi.org/10.1038/s41467-022-35454-4).
INSTRUMENT(S): SomaScan assay v4.1
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Plasma
SUBMITTER:
Jack Gisby
LAB HEAD: James E. Peters
PROVIDER: PAD000003 | Pride | 2025-03-17
REPOSITORIES: Pride
ACCESS DATA